NDC 70000-0263-01 - LEADER CHILDRENS IBUPROFEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0263
- Requested NDC
- 70000-0263-01
- Package NDCs from labels
- 70000-0263-1, 70000-0263-2, 70000-0263-3, 70000-0263-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2025-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEADER CHILDRENS IBUPROFEN - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2025-03-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 120 mL in 1 BOTTLE | SUSPENSION | 120 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 240 mL in 1 BOTTLE | SUSPENSION | 240 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 150 mL in 1 BOTTLE | SUSPENSION | 150 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0263 | LEADER CHILDRENS IBUPROFEN (IBUPROFEN) SUSPENSION [CARDINAL HEALTH 110, LLC. DBA LEADER] | 5 | Current NDC, Legacy NDC, 6 package rows | 20250305_913a4bd0-0784-45b4-b05e-3e7c016bbb86.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0263-1 | ML - Milliliter | 70000-0263 | fbb179f2-5d83-4b39-a4c8-7f816a8d06e2 | 1 | 2017-11-06 |
| 70000-0263-2 | ML - Milliliter | 70000-0263 | fbe88e6f-ef78-4794-b3b0-585c7211eea8 | 1 | 2017-11-06 |
| 70000-0263-3 | ML - Milliliter | 70000-0263 | 5146b58d-9db9-4309-b673-3ed748b15b86 | 1 | 2018-03-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | P & L Development, LLC | 6d1c9a64-c83c-4b3d-9245-704b94cb367c | 2024-07-30 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Amneal Pharmaceuticals of New York LLC | faebc392-0fd9-4c71-8471-beba10dda022 | 2024-07-29 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen PM | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | KROGER COMPANY | 15e649c4-d75f-e8c1-e063-6294a90a7747 | 2024-07-26 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Actavis Pharma, Inc. | 3d156d13-25d8-4cfc-8285-5f7ebf48cf45 | 2024-07-24 | Boxed warning, Warnings, Adverse reactions | 197803 WK2XYI10QM |
| IBU | IBUPROFEN | NuCare Pharmaceuticals,Inc. | 678e2d16-33f3-67a7-e053-2991aa0a1132 | 2024-07-18 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Amneal Pharmaceuticals of New York LLC | 75d963b9-3675-44ff-bc6b-83461bed1b67 | 2024-07-18 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Amneal Pharmaceuticals of New York LLC | 57cdd1df-a303-4265-a2d6-1d0b87105a28 | 2024-07-18 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Amneal Pharmaceuticals of New York LLC | 8df77ead-27eb-4f6f-95a9-f68d3e9cfa71 | 2024-07-18 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Advil | IBUPROFEN TABLETS, COATED | Lil' Drug Store Products, Inc. | dd302e18-39e9-7e1a-e053-2a95a90a5f7c | 2024-07-17 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | NuCare Pharmaceuticals,Inc. | 54b25106-5580-119d-e054-00144ff88e88 | 2024-07-17 | WK2XYI10QM | |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Advanced Rx of Tennessee, LLC | 1d625438-34dc-fbba-e063-6294a90afd2f | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | American Health Packaging | 58fa9952-c8ab-4ebb-a073-15cc45f4832a | 2024-07-16 | Adverse reactions | XF417D3PSL |
| Ibuprofen Oral | IBUPROFEN ORAL | NuCare Pharmaceuticals,Inc. | 84764eda-7446-5b16-e053-2991aa0abd7c | 2024-07-15 | Warnings | 197803 WK2XYI10QM |
| Thompson Safety Eyewash | WATER | Thompson Safety | 1d0e96cf-245b-cfb7-e063-6294a90a4ced | 2024-07-12 | Warnings | 059QF0KO0R |
| ibuprofen | IBUPROFEN | Bryant Ranch Prepack | 22cb2ccc-ba4d-4069-8334-f886f0e3e802 | 2024-07-12 | Warnings | WK2XYI10QM |
| Foster and Thrive Infants Ibuprofen | IBUPROFEN | Strategic Sourcing Services LLC | fe3092af-9a7b-4189-af89-31be8d6fed53 | 2024-07-12 | Warnings | WK2XYI10QM |
| IBUPROFEN AND FAMOTIDINE | IBUPROFEN AND FAMOTIDINE | Camber Pharmaceuticals, Inc. | 7dc158a2-fdfa-4a5f-8c28-0ce5650991db | 2024-07-11 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Zenibell Snail IntensiveCream | GLYCERIN | MISOCOS | 97c19dca-237c-c968-e053-2a95a90aeae7 | 2024-07-05 | Warnings | PDC6A3C0OX |
| Zenibell Snail Intensive Toner | GLYCERIN | MISOCOS | 97c1b556-824d-bef7-e053-2a95a90ae1f2 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell | GLYCERIN | MISOCOS | 980fcaea-27ba-da49-e053-2995a90ad506 | 2024-07-05 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.